Business Description
iBio Inc
NAICS : 325412
SIC : 2834
ISIN : US4510332038
Description
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.17 | |||||
| Equity-to-Asset | 0.27 | |||||
| Debt-to-Equity | 1.79 | |||||
| Debt-to-EBITDA | -0.85 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -14.14 | |||||
| Beneish M-Score | -7.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 21.2 | |||||
| 3-Year EPS without NRI Growth Rate | 46.1 | |||||
| 3-Year FCF Growth Rate | 19.9 | |||||
| 3-Year Book Growth Rate | -57.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 30.57 | |||||
| 14-Day RSI | 34.25 | |||||
| 6-1 Month Momentum % | -30.08 | |||||
| 12-1 Month Momentum % | -82.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.91 | |||||
| Quick Ratio | 0.91 | |||||
| Cash Ratio | 0.13 | |||||
| Days Sales Outstanding | 5097.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -53.6 | |||||
| Shareholder Yield % | -38.88 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -41466 | |||||
| Net Margin % | -54568 | |||||
| FCF Margin % | -37874.47 | |||||
| ROE % | -184.35 | |||||
| ROA % | -65.24 | |||||
| ROIC % | -65.68 | |||||
| ROC (Joel Greenblatt) % | -107.47 | |||||
| ROCE % | -108.51 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 45.24 | |||||
| PB Ratio | 0.67 | |||||
| Price-to-Tangible-Book | 1.61 | |||||
| EV-to-EBIT | -1.38 | |||||
| EV-to-EBITDA | -1.47 | |||||
| EV-to-Revenue | 570.06 | |||||
| EV-to-FCF | -1.57 | |||||
| Earnings Yield (Greenblatt) % | -72.7 | |||||
| FCF Yield % | -129.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
iBio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.047 | ||
| EPS (TTM) (€) | -14.025 | ||
| Beta | 0.27 | ||
| Volatility % | 58.5 | ||
| 14-Day RSI | 34.25 | ||
| 14-Day ATR (€) | 0.000158 | ||
| 20-Day SMA (€) | 3.72 | ||
| 12-1 Month Momentum % | -82.94 | ||
| 52-Week Range (€) | 3.72 - 19.7 | ||
| Shares Outstanding (Mil) | 8.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
iBio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
iBio Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
iBio Inc Frequently Asked Questions
What is iBio Inc(STU:0JV0)'s stock price today?
The current price of STU:0JV0 is €3.72. The 52 week high of STU:0JV0 is €19.70 and 52 week low is €3.72.
When is next earnings date of iBio Inc(STU:0JV0)?
The next earnings date of iBio Inc(STU:0JV0) is 2024-05-15 Est..
Does iBio Inc(STU:0JV0) pay dividends? If so, how much?
iBio Inc(STU:0JV0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers